These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 31801287)
21. Sepsis, thrombosis and organ dysfunction. Semeraro N; Ammollo CT; Semeraro F; Colucci M Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311 [TBL] [Abstract][Full Text] [Related]
22. The endothelium in sepsis: source of and a target for inflammation. Hack CE; Zeerleder S Crit Care Med; 2001 Jul; 29(7 Suppl):S21-7. PubMed ID: 11445730 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*. Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503 [TBL] [Abstract][Full Text] [Related]
24. The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment. Cunneen J; Cartwright M AACN Clin Issues; 2004; 15(1):18-44. PubMed ID: 14767363 [TBL] [Abstract][Full Text] [Related]
25. Controlling the complement system in inflammation. Kirschfink M Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114 [TBL] [Abstract][Full Text] [Related]
26. New therapies for sepsis. Cunnington A; Nadel S Curr Top Med Chem; 2008; 8(7):603-14. PubMed ID: 18473886 [TBL] [Abstract][Full Text] [Related]
27. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?]. Karima R Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996 [TBL] [Abstract][Full Text] [Related]
28. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Eisele B; Lamy M Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782 [TBL] [Abstract][Full Text] [Related]
29. Advances in the understanding and treatment of sepsis-induced immunosuppression. Venet F; Monneret G Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343 [TBL] [Abstract][Full Text] [Related]
30. Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults. Eppensteiner J; Davis RP; Barbas AS; Kwun J; Lee J Front Immunol; 2018; 9():190. PubMed ID: 29472928 [TBL] [Abstract][Full Text] [Related]
31. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Marshall JC Crit Care Med; 2001 Jul; 29(7 Suppl):S99-106. PubMed ID: 11445742 [TBL] [Abstract][Full Text] [Related]
32. Cytokine modulation in sepsis and septic shock. Zanotti S; Kumar A; Kumar A Expert Opin Investig Drugs; 2002 Aug; 11(8):1061-75. PubMed ID: 12150702 [TBL] [Abstract][Full Text] [Related]
33. Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients. Ramakers BP; Giamarellos-Bourboulis EJ; Tasioudis C; Coenen MJ; Kox M; Vermeulen SH; Groothuismink JM; van der Hoeven JG; Routsi C; Savva A; Prekates A; Diamantea F; Sinapidis D; Smits P; Toutouzas K; Riksen NP; Pickkers P; Shock; 2015 Dec; 44(6):542-7. PubMed ID: 26529652 [TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Mei SH; Haitsma JJ; Dos Santos CC; Deng Y; Lai PF; Slutsky AS; Liles WC; Stewart DJ Am J Respir Crit Care Med; 2010 Oct; 182(8):1047-57. PubMed ID: 20558630 [TBL] [Abstract][Full Text] [Related]